Regeneron Pharmaceuticals Inc
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. Recalculated at least weekly and after every earnings report.
How we calculate it →Analyst Sentiment
Regeneron is fairly valued at current levels. With our price target of $809.65 suggesting modest upside, the stock appears to be trading near fair value. Consider your portfolio allocation and investment timeline before making a decision.
The 24/7 Factor
5-Year Projection
Prediction History
| Date | Price Target | Stock Price | Rating | Upside |
|---|---|---|---|---|
| $807.98 | $805.02 | HOLD | +0.4% | |
| $808.01 | $790.74 | HOLD | +2.2% | |
| $816.83 | $746.54 | BUY | +9.4% | |
| $805.13 | $735.20 | BUY | +9.5% | |
| $849.72 | $788.04 | BUY | +7.8% | |
| $893.90 | $784.85 | BUY | +13.9% | |
| $917.93 | $781.49 | BUY | +17.5% | |
| $950.19 | $827.72 | BUY | +14.8% |
Frequently Asked Questions
What is the REGN stock price prediction for 2030?
Looking ahead to 2030, our model projects REGN could trade at an average price of $901.88, with a potential range between $676.41 and $1,127.35. This represents a potential 11.7% return from today’s price. Long-term forecasts depend heavily on company execution, competitive dynamics, and broader market conditions.
Is REGN a buy, sell, or hold right now?
24/7 Wall St. currently rates REGN as a HOLD. Near fair value (0.2%) Among Wall Street analysts, 17 rate it Buy, 9 rate it Hold, and 1 rate it Sell.
What is the REGN stock price target in an optimistic scenario?
In our optimistic scenario for REGN, the stock could reach $895.04 over the next 12 months, representing a 10.8% gain from today’s price. This scenario assumes favorable conditions materialize, including strong earnings growth, positive market sentiment, and successful execution of company initiatives.
What is the downside risk for REGN stock?
In our conservative scenario, REGN could trade as low as $726.28 over the next 12 months, representing a 10.1% decline from current levels. This scenario accounts for potential headwinds including earnings misses, competitive pressures, or broader market weakness.
Projections are estimates based on current data, updated daily. Not investment advice. Learn how we calculate these projections →